Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17ClN2O4S |
InChIKeyAUTAJMGNRLHARZ-UHFFFAOYSA-N |
CAS Registry1617518-22-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 Jul 2014 |